Literature DB >> 20405227

Non-prescription syringe sales in California: a qualitative examination of practices among 12 local health jurisdictions.

Valerie J Rose1, Glenn Backes, Alexis Martinez, Willi McFarland.   

Abstract

Legislation permitting non-prescription syringe sales (NPSS) was passed in 2004 in California as a structural intervention designed to expand access to syringes for injection drug users. As of December 2009, 19 of California's 61 local health jurisdictions (LHJs) have approved policies to authorize pharmacies to sell non-prescription syringes. The legislation faces termination in 2010 if current evaluation efforts fail to demonstrate outcomes defined in the legislation. Using qualitative methods, we examined the systems and procedures associated with implementation; identified facilitators and barriers to implementation among 12 LHJs, and documented the role of public health in initiating and sustaining local programs. We identified consistent activities that led to policy implementation among LHJs and discovered several barriers that were associated with failure to implement local programs. Factors leading to NPSS were public health leadership; an inclusive planning process, marketing the program as a public health initiative; learning from others' efforts, successes, and failures; and identifying acceptable syringe disposal options in advance of program implementation. Health departments that were confronted with political and moral arguments lost momentum and ultimately assigned a lower priority to the initiative citing the loss of powerful public health advocates or a lack of human resources. Additional barriers were law enforcement, elected officials, and pharmacy opposition, and failure to resolve syringe disposal options to the satisfaction of important stakeholders. The lessons learned in this study should provide useful guidance for the remaining LHJs in California without NPSS programs.

Entities:  

Mesh:

Year:  2010        PMID: 20405227      PMCID: PMC2900573          DOI: 10.1007/s11524-010-9445-5

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  31 in total

1.  Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000.

Authors:  R N Bluthenthal; A H Kral; L Gee; J Lorvick; L Moore; K Seal; B R Edlin
Journal:  J Acquir Immune Defic Syndr       Date:  2001-11-01       Impact factor: 3.731

2.  Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.

Authors:  N U Cotten-Oldenburg; P Carr; J M DeBoer; E K Collison; G Novotny
Journal:  J Acquir Immune Defic Syndr       Date:  2001-06-01       Impact factor: 3.731

3.  Harm reduction in the health care system: the legality of prescribing and dispensing syringes to drug users.

Authors:  S Burris; P Lurie; M Ng
Journal:  Health Matrix Clevel       Date:  2001

4.  Structural and environmental HIV prevention for gay and bisexual men.

Authors:  D Wohlfeiler
Journal:  AIDS       Date:  2000-06       Impact factor: 4.177

5.  Structural interventions to encourage primary HIV prevention among people living with HIV.

Authors:  M D Shriver; C Everett; S F Morin
Journal:  AIDS       Date:  2000-06       Impact factor: 4.177

6.  Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.

Authors:  Crystal M Fuller; Jennifer Ahern; Liza Vadnai; Phillip O Coffin; Sandro Galea; Stephanie H Factor; David Vlahov
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

7.  Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001.

Authors:  Robert Heimer; Scott Clair; Wei Teng; Lauretta E Grau; Kaveh Khoshnood; Merrill Singer
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

8.  Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange.

Authors:  David R Gibson; Richard Brand; Kim Anderson; James G Kahn; Daniel Perales; Joseph Guydish
Journal:  J Acquir Immune Defic Syndr       Date:  2002-10-01       Impact factor: 3.731

9.  Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.

Authors:  J A Hahn; K Page-Shafer; P J Lum; K Ochoa; A R Moss
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

10.  Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.

Authors:  Alan Neaigus; Mingfang Zhao; V Anna Gyarmathy; Linda Cisek; Samuel R Friedman; Robert C Baxter
Journal:  J Urban Health       Date:  2008-03-14       Impact factor: 3.671

View more
  3 in total

1.  Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California.

Authors:  Alex H Kral; Richard S Garfein
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

2.  Primary and secondary analysis of local elected officials' decisions to support or oppose pharmacy sale of syringes in California.

Authors:  Glenn Backes; Valerie J Rose
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

3.  Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.

Authors:  Jennifer L Syvertsen; Robin A Pollini
Journal:  Int J Drug Policy       Date:  2019-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.